This post was originally published on this site
(Reuters) – CVS Health Corp (NYSE:CVS) said on Wednesday it expects to administer 70% to 80% fewer COVID-19 vaccines in 2022 compared with last year, adding that in-store diagnostic testing could fall 40% to 50%.
The company administered more COVID-19 vaccine boosters in the fourth quarter instead of the first quarter of 2022, as it had previously expected, executives said on a post-earnings call.
